The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
Open accessAbstract
Cannabis dependence is a substantial public health problem. Behavioral treatments have shown promise, but there are no effective medications for cannabis dependence. The purpose of this study was to evaluate the safety and efficacy of dronabinol, a synthetic form of delta-9-tetrahydrocannabinol, a naturally occurring pharmacologically active component of marijuana, in treating cannabis dependence. 156 cannabis-dependent adults were enrolled in a randomized, double-blind, placebo-controlled, 12-week trial. After a 1-week placebo lead-in phase, participants were randomized to receive dronabinol 20mg twice a day or placebo. Doses were maintained until the end of week 8 and then tapered off over 2 weeks. All participants received weekly motivational enhancement and relapse prevention therapy. Marijuana use was assessed using the timeline follow back method. There was no significant difference between treatment groups in the proportion of participants who achieved 2 weeks of abstinence at the end of the maintenance phase (dronabinol: 17.7%; placebo: 15.6%). Although both groups showed a reduction in marijuana use over time, there were no differences between the groups. Treatment retention was significantly higher at the end of the maintenance phase on dronabinol (77%), compared to placebo (61%) (P=.02), and withdrawal symptoms were significantly lower on dronabinol than placebo (P=.02). This is the first trial using an agonist substitution strategy for treatment of cannabis dependence. Dronabinol showed promise, it was well-tolerated, and improved treatment retention and withdrawal symptoms. Future trials might test higher doses, combinations of dronabinol with other medications with complementary mechanisms, or with more potent behavioral interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“although the CB1 agonist dronabinol has reduced cannabis withdrawal symptoms and increased retention in treatment when compared with placebo in early studies 51”
From Psychosocial and pharmacological interventions for the treatment of cannabis use disorder (2018) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
Diagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2024) · doi:10.4135/9781071886229.n145 · Cited by 2,806
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,564
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials
Dennis, M. L., Godley, S. H., Diamond, G., Tims, F. M., Babor, T. F., Donaldson, J., Liddle, H. A., Titus, J. C., Kaminer, Y., Webb, C. P. M., et al. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2003.09.005 · Cited by 780
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721 · cited 2×
“…varenicline, methadone, buprenorphine) reduce withdrawal symptoms, improve treatment retention, reduce the reinforcing effects of the addictive drug, and promote abstinence (Comer et al., 2001; Garrison and Dugan, 2009; Mattick et al., 2009; Schottenfeld et al., 2008; Stead et al., 2008).”
BackgroundComparison of extended versus brief treatments for marijuana use.
Stephens, R. S., Roffman, R. A., & Curtin, L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.898 · Cited by 711
Prevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004) · JAMA · doi:10.1001/jama.291.17.2114 · Cited by 537
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533
The development of a cocaine craving questionnaire
Tiffany, S. T., Singleton, E. G., Haertzen, C. A., & Henningfield, J. E. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90042-o · Cited by 426
Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030013002 · Cited by 348
Marijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348 · cited 1×
“2.3.2 Marijuana Withdrawal—Marijuana withdrawal symptoms were assessed twice a week using 10 symptoms from the Withdrawal Checklist and identified by Budney et al. (1999) as the withdrawal discomfort score (WDS).”
MethodInfluentialBuprenorphine: A Unique Drug with Complex Pharmacology
Lutfy, K., & Cowan, A. (2004) · Current Neuropharmacology · doi:10.2174/1570159043359477 · Cited by 343
The Principles of Addiction Medicine
Karch, S. B. (2007) · CRC Press eBooks · doi:10.1201/9781420054446-5 · Cited by 331
SAFTEE: a technique for the systematic assessment of side effects in clinical trials.
Levine, J., & Schooler, N. (1986) · PubMed · Cited by 330
A randomized controlled trial of brief cognitive–behavioral interventions for cannabis use disorder
Copeland, J., Swift, W., Roffman, R., & Stephens, R. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00179-9 · Cited by 322 · cited 1×
“…progress in the development of cannabis-dependence-specific psychotherapy interventions, the results of several psychotherapy trials indicate that most dependent patients in treatment do not achieve abstinence (Copeland et al., 2001; Dennis et al., 2004; MTPRG, 2004; Stephens et al., 2000).”
BackgroundBrief treatments for cannabis dependence: Findings from a randomized multisite trial
Babor, T. F., & The Marijuana Treatment Project Research Group (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.3.455 · Cited by 313
Budney, A. J., Moore, B. A., Rocha, H. L., & Higgins, S. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.4.2.307 · Cited by 290
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J. A., Bennett, A., Zúbaran, C., & Foltin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300310 · Cited by 264
Marijuana Craving Questionnaire: development and initial validation of a self‐report instrument
Heishman, S. J., Singleton, E. G., & Liguori, A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.967102312.x · Cited by 232
Principles of addiction medicine
Ries, R. R., Fiellin, D. A., Miller, S. C., & Saitz, R. (2009) · Cited by 218
Reliability and validity of a short form of the Marijuana Craving Questionnaire
Heishman, S. J., Evans, R. J., Singleton, E. G., Levin, K. H., Copersino, M. L., & Gorelick, D. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.12.010 · Cited by 212
Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapse
Budney, A. J., Vandrey, R. G., Hughes, J. R., Thostenson, J. D., & Bursac, Z. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.01.002 · Cited by 195
Svoboda, G. H., Neuss, N., & Gorman, M. (1959) · Journal of the American Pharmaceutical Association (Scientific ed ) · doi:10.1002/jps.3030481115 · Cited by 190
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A., & Bahrenburg, B. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.014 · Cited by 180
Wang, D., Cummins, C., Bayliss, S. E., Sandercock, J., & Burls, A. (2008) · Health Technology Assessment · doi:10.3310/hta12360 · Cited by 176
Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
Haney, M., Hart, C. L., Vosburg, S. K., Comer, S. D., Collins, S. L., & Foltin, R. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1020-8 · Cited by 173
Poling, J. C., Oliveto, A. H., Petry, N. M., Sofuoglu, M., Gonsai, K., Gonzalez, G. M., Martell, B. A., & Kosten, T. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.219 · Cited by 168
Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders
Nunes, E. V., Quitkin, F. M., Donovan, S. J., Deliyannides, D. A., Ocepek‐Welikson, K., Koenig, T., Brady, R., McGrath, P. J., & WOODY, G. E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.153 · Cited by 166
Self-citationA Randomized Trial of Contingency Management for Adolescent Marijuana Abuse and Dependence
Stanger, C., Budney, A., Kamon, J., & Thostensen, J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.009 · Cited by 150
Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes
Mariani, J. J., Brooks, D., Haney, M., & LEVIN, F. R. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.08.008 · Cited by 141
Self-citationVarenicline: A first-line treatment option for smoking cessation
Garrison, G. D., & Dugan, S. E. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.03.021 · Cited by 140
Wang, D., Connock, M., Barton, P., Fry-Smith, A., Aveyard, P., & Moore, D. (2008) · Health Technology Assessment · doi:10.3310/hta12020 · Cited by 137
Bupropion SR worsens mood during marijuana withdrawal in humans
Haney, M., Ward, A. S., Comer, S. D., Hart, C. L., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130000657 · Cited by 135
Treatment of Cannabis Use Disorders: A Review of the Literature
Nordstrom, B. R., & LEVIN, F. R. (2007) · American Journal on Addictions · doi:10.1080/10550490701525665 · Cited by 125
Self-citationLevodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform
Schmitz, J. M., Mooney, M. E., Moeller, F. G., Stotts, A. L., Green, C., & Grabowski, J. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.004 · Cited by 124
Kosten, T. R., Oliveto, A. H., Feingold, A., Poling, J. C., Sevarino, K. A., McCance‐Katz, E. F., Stine, S. M., Gonzalez, G. M., & Gonsai, K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00032-2 · Cited by 121
Donny, E. C., Brasser, S. M., Bigelow, G. E., Stitzer, M. L., & WALSH, S. L. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01232.x · Cited by 114
Levin, F. R., McDowell, D., Evans, S. M., Nunes, E., Akerele, E., Donovan, S., & Vosburg, S. K. (2004) · The American Journal on Addictions · doi:10.1080/10550490490265280 · Cited by 113
Self-citationUse of Oral Topiramate to Promote Smoking Abstinence Among Alcohol-Dependent Smokers
Johnson, B. A., Ait‐Daoud, N., Akhtar, F. Z., & Javors, M. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1600 · Cited by 110
Pharmacotherapy for Cannabis Dependence
Vandrey, R. G., & Haney, M. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00001 · Cited by 109
Budney, A., Radonovich, K., Higgins, S. T., & Wong, C. J. (1998) · Experimental and clinical psychopharmacology · doi:10.1037/1064-1297.6.4.419 · Cited by 107
Abuse potential of dronabinol (Marinol).
Calhoun, S. R., Galloway, G. P., & Smith, D. E. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399689 · Cited by 103
Assessment of Medication Compliance in Alcoholics through UV Light Detection of a Riboflavin Tracer
Boca, F. K. D., Kranzler, H. R., Brown, J., & Körner, P. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01142.x · Cited by 100
Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60954-x · Cited by 99
Imipramine treatment of cocaine abuse: possible boundaries of efficacy
Nunes, E. V., McGrath, P. J., Quitkin, F. M., Ocepek‐Welikson, K., Stewart, J. W., Koenig, T., Wager, S., & Klein, D. F. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01161-6 · Cited by 95
Self-citationNefazodone decreases anxiety during marijuana withdrawal in humans
Haney, M., Hart, C. L., Ward, A. S., & Foltin, R. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1210-3 · Cited by 91
Carpenter, K. M., McDowell, D., Brooks, D. J., Cheng, W. Y., & Levin, F. R. (2009) · The American Journal on Addictions · doi:10.1080/10550490802408936 · Cited by 89
Self-citationA placebo-controlled trial of buspirone for the treatment of marijuana dependence
McRae‐Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., Wahlquist, A. E., Simpson, S. A., & Brady, K. T. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.022 · Cited by 84
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse
Haney, M., Hart, C. L., Vosburg, S. K., Comer, S. D., Collins, S. L., Cooper, Z. D., & Foltin, R. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1888-6 · Cited by 79
Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans
Comer, S. D., Collins, E. D., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130000623 · Cited by 77
Attempts to stop or reduce marijuana use in non-treatment seekers
HUGHES, J., Peters, E. N., CALLAS, P. W., Budney, A. J., & Livingston, A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.031 · Cited by 76
Systematic review and meta-analysis of combination therapy for smoking cessation
shah, S. D., Wilken, L. A., Winkler, S., & Lin, S. (2008) · Journal of the American Pharmacists Association · doi:10.1331/japha.2008.07063 · Cited by 69
Effects of oral THC maintenance on smoked marijuana self-administration
Hart, C. L., Haney, M., Ward, A. S., Fischman, M. W., & Foltin, R. W. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00084-4 · Cited by 68
Johnson, B. A., Ait‐Daoud, N., & Roache, J. D. (2005) · Journal of Studies on Alcohol Supplement · doi:10.15288/jsas.2005.s15.157 · Cited by 61
Reinforcing effects of oral Δ9-THC in male marijuana smokers in a laboratory choice procedure
Hart, C. L., Haney, M., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2234-2 · Cited by 58
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper, Z. D., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1875-y · Cited by 58
Choosing a behavioral therapy platform for pharmacotherapy of substance users
Carroll, K. M., Kosten, T. R., & Rounsaville, B. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.007 · Cited by 58
Reus, V. I., & Smith, B. J. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01885.x · Cited by 44
Severity of Dependence and Motivation for Treatment
LEVIN, F. R., Brooks, D. J., Bisaga, A. M., Raby, W. N., Rubin, E., Aharonovich, E., & Nunes, E. V. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n01_06 · Cited by 23
Self-citationLEVIN, F. R., Mariani, J. J., Brooks, D. J., Xie, S., & Murray, K. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.021 · Cited by 21
Self-citation
Cited by
Sorted by citations
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Neuroscience of Addiction: Relevance to Prevention and Treatment
Volkow, N. D., & Boyle, M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101174 · Cited by 389
A Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306
Metadata
- Authors
- Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V.
- Affiliations
- New York State Psychiatric Institute (US)
- Corresponding author
- Levin, Frances R.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 116
- Issue
- 1-3
- Pages
- 142-150
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC3154755
- OpenAlex
- W1979308736
- Cited by
- 232
- References
- 64
- Citations by year
- 2026: 12 · 2025: 7 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 15 · 2020: 13 · 2019: 12 · 2018: 23 · 2017: 11 · 2016: 14 · 2015: 19 · 2014: 20 · 2013: 9 · 2012: 17
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (K02 000465)
- National Institute on Drug Abuse (K24DA022412, P50DA009236, K24DA029647, T32DA007294)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- dronabinol, cannabis use disorder, delta-9-tetrahydrocannabinol, treatment retention, withdrawal symptoms, motivational enhancement therapy, abstinence, drug safety and tolerability
- MeSH terms
- Adult, Cannabinoids, Marijuana Abuse, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Marijuana Smoking, Middle Aged, Placebos, Psychotherapy, Psychotropic Drugs, Substance Withdrawal Syndrome, Dronabinol, Behavior, Addictive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
